Brazilian national health regulator Anvisa has approved the
COVID-19 vaccine produced by Pfizer (PFE.N) and BioNTech for
children aged between six months and four years, the government
body said in a statement Friday night, Trend reports citing Reuters .
The move broadens the availability of the vaccine, which is sold
under the brand name Comirnaty for adults and is already available
in Brazil for older age groups.
Brazil's vaccination rates are already among the world's
highest, with almost 90% of the population having received at least
one dose, according to the Our World in Data project, which
collects official numbers from governments worldwide.
On Friday, the South American country reported 97 deaths
nationwide due to the coronavirus, far lower than the daily peak of
4,250 recorded in April 2021.
Follow us on Twitter @AzerNewsAz
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.